Gablofen (baclofen injection)
Recall D-1742-2019, part of FDA recall event 83280. See Piramal Critical Care, Inc.'s company page.
Piramal Critical Care, Inc. started this Class II drug recall on Jul 8, 2019 (voluntary: firm initiated); FDA lists it as terminated, terminated Mar 9, 2021.
- Classification: Class II
- Started: Jul 8, 2019
- Status: Terminated
Failed Impurities/Degradation Specification -This recall is being initiated as a precaution due to the presence of an unknown impurity observed during shelf life of the product.
- Product
- Gablofen (baclofen injection), 50 mcg/mL, Single Use Syringe, Rx only, packaged in a box containing one 1 mL syringe, Distributed by: Primal Critical Care, Inc., 3950 Schelden Circle Bethlehem, PA, 18017, NDC 66794-151-01
- Quantity
- Lot 2155-111 (1,418 boxes) and Lot 2155-111A (5,640 boxes)
- Lots and codes
- Lot #: 2155-111, 2155-111A, Exp 6/20
- Distribution
- USA Nationwide
- Recalling firm
- Piramal Critical Care, Inc., Bethlehem, PA, United States
- How the firm notified
- Letter
- FDA classified
- Aug 13, 2019
Newest first, one product per recall event; search them all
- Rocuronium Bromide Injection 50mg/5 mL, 5mL Multi-Dose Vial, Rx only, Manufactured for: Piramal Critical Care,…D-0019-2022 · Class II · Sep 10, 2021 · Terminated
- Sevoflurane, USP (Inhalation Anesthetic), Rx Only, 250 mL Amber Bottle. Manufactured By: Piramal Critical Care, 3950…D-1262-2014 · Class II · Apr 7, 2014 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports